News Releases

This information is part of the archives and is no longer current and may no longer be accurate.

Date	Title
May 04, 2022	DURECT Corporation Reports First Quarter 2022 Financial Results and Update of Programs
Apr 27, 2022	DURECT Corporation to Announce First Quarter 2022 Financial Results and Provide Business Update on May 4
Mar 23, 2022	DURECT Corporation To Present at the 2022 Cantor Fitzgerald Virtual Rare Orphan Disease Summit
Mar 09, 2022	DURECT Corporation Fireside Chat at the Oppenheimer 32nd Annual Healthcare Conference
Mar 07, 2022	DURECT Corporation Reports Fourth Quarter and Full Year 2021 Financial Results and Update of Programs
Mar 01, 2022	DURECT Corporation Doses First European Patient in Phase 2b AHFIRM Study of Larsucosterol(DUR-928) in Severe Alcohol-Associated Hepatitis
Feb 28, 2022	DURECT Corporation to Announce Fourth Quarter and Full Year 2021 Financial Results and Provide Business Update on March 7
Jan 06, 2022	DURECT Corporation to Participate in H.C. Wainwright Bioconnect Conference

Investor Relations